19410571|t|Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barre syndrome and other neurological disorders.
19410571|a|BACKGROUND: Guillain-Barre syndrome (GBS) is an autoimmune inflammatory polyradiculoneuropathy that causes acute areflexic paralysis with a high risk of respiratory failure. Previously, using two-dimensional gel electrophoresis and mass spectrometry, we found that the transthyretin level was altered in the cerebrospinal fluid (CSF) of GBS patients when compared to that in CSF of control patients. METHODS: We used enzyme-linked immunosorbent assay (ELISA) to measure the transthyretin levels in the CSF and serum from 22 GBS, 4 Miller-Fisher syndrome (MFS), 9 chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), 22 multiple sclerosis (MS), 10 Alzheimer's disease (AD), and 6 viral meningitis (VM) patients, and 18 controls. RESULTS: The results show that CSF transthyretin concentration of the GBS patients is significantly higher than that of the control, MS, AD and VM patients (p<0.05), although not significantly different from that of MFS and CIDP patients. CONCLUSION: The increased CSF transthyretin level may be explained by barrier dysfunction or decreased CSF flow in the GBS patients along with increased intrathecal synthesis of transthyretin that might be a protective response to nerve damage.
19410571	12	25	transthyretin	Gene	7276
19410571	70	78	patients	Species	9606
19410571	84	107	Guillain-Barre syndrome	Disease	MESH:D020275
19410571	118	140	neurological disorders	Disease	MESH:D009461
19410571	154	177	Guillain-Barre syndrome	Disease	MESH:D020275
19410571	179	182	GBS	Disease	MESH:D020275
19410571	190	236	autoimmune inflammatory polyradiculoneuropathy	Disease	MESH:D020277
19410571	255	274	areflexic paralysis	Disease	MESH:D010243
19410571	295	314	respiratory failure	Disease	MESH:D012131
19410571	411	424	transthyretin	Gene	7276
19410571	479	482	GBS	Disease	MESH:D020275
19410571	483	491	patients	Species	9606
19410571	532	540	patients	Species	9606
19410571	616	629	transthyretin	Gene	7276
19410571	666	669	GBS	Disease	MESH:D020275
19410571	673	695	Miller-Fisher syndrome	Disease	MESH:D019846
19410571	697	700	MFS	Disease	MESH:D019846
19410571	705	762	chronic inflammatory demyelinating polyradiculoneuropathy	Disease	MESH:D020277
19410571	764	768	CIDP	Disease	MESH:D020277
19410571	774	792	multiple sclerosis	Disease	MESH:D009103
19410571	794	796	MS	Disease	MESH:D009103
19410571	802	821	Alzheimer's disease	Disease	MESH:D000544
19410571	823	825	AD	Disease	MESH:D000544
19410571	834	850	viral meningitis	Disease	MESH:D008587
19410571	852	854	VM	Disease	MESH:D008587
19410571	856	864	patients	Species	9606
19410571	918	931	transthyretin	Gene	7276
19410571	953	956	GBS	Disease	MESH:D020275
19410571	957	965	patients	Species	9606
19410571	1016	1018	MS	Disease	MESH:D009103
19410571	1020	1022	AD	Disease	MESH:D000544
19410571	1027	1029	VM	Disease	MESH:D008587
19410571	1030	1038	patients	Species	9606
19410571	1099	1102	MFS	Disease	MESH:D019846
19410571	1107	1111	CIDP	Disease	MESH:D020277
19410571	1112	1120	patients	Species	9606
19410571	1152	1165	transthyretin	Gene	7276
19410571	1241	1244	GBS	Disease	MESH:D020275
19410571	1245	1253	patients	Species	9606
19410571	1300	1313	transthyretin	Gene	7276
19410571	1353	1365	nerve damage	Disease	MESH:D000080902
19410571	Association	MESH:D000080902	7276
19410571	Association	MESH:D020275	7276

